Primary Care Treatment for Severe Lower Spine Arthritis
Initial Pharmacologic Management
- The American College of Rheumatology recommends prescribing NSAIDs at maximum tolerated doses, weighing cardiovascular and gastrointestinal risks against benefits, as first-line treatment for severe arthritis in the lower spine 1
- Continuous NSAID use is preferred over on-demand dosing for patients who respond well and remain symptomatic, according to the European League Against Rheumatism 1, 3
- Approximately 75% of patients with axial spondyloarthritis show good or very good response within 48 hours of full-dose NSAID therapy, as reported by the Assessment of SpondyloArthritis international Society 4
- If the first NSAID is ineffective after 2-4 weeks, trial a different NSAID before escalating therapy, as suggested by the American College of Rheumatology 2
- For patients with gastrointestinal risk factors, consider COX-2 selective NSAIDs or add gastroprotective agents, according to the European League Against Rheumatism 5
Non-Pharmacologic Interventions
- All patients must be educated about their condition and encouraged to exercise regularly, as recommended by the American College of Rheumatology 1, 3, 6
- Structured physical therapy programs should be considered and are often more beneficial than home exercises alone, according to the American College of Rheumatology 2
- Smoking cessation is essential, as smoking worsens disease progression, as reported by the European League Against Rheumatism 1, 3
- Regular exercise improves pain, stiffness, and function, according to the American College of Rheumatology 1, 6
When to Refer to Rheumatology
- Refer patients with chronic low back pain (>3 months) starting before age 45 who have inflammatory back pain characterized by waking at night due to back pain, as recommended by the American College of Rheumatology 2, 4, 7
- Persistently high disease activity despite 2-4 weeks of optimal NSAID therapy is a referral trigger, as suggested by the American College of Rheumatology 1, 2
- Difficulties performing activities of daily living despite NSAID treatment is another referral trigger, according to the American College of Rheumatology 2
Important Clinical Pitfalls
- Do not rule out axial spondyloarthritis based solely on negative HLA-B27 or normal inflammatory markers (ESR/CRP), as recommended by the American College of Rheumatology 2
- The typical delay between symptom onset and diagnosis is 5-7 years—maintain high clinical suspicion, according to the Assessment of SpondyloArthritis international Society 2, 4
- Plain radiographs may be normal early in disease; MRI is more sensitive for detecting sacroiliitis, as reported by the European League Against Rheumatism 7
Medications to Avoid
- Do not use conventional DMARDs (methotrexate, sulfasalazine, leflunomide) for purely axial disease—they are ineffective, as recommended by the American College of Rheumatology 1, 5, 6
- Sulfasalazine may only be considered if peripheral arthritis is present, according to the European League Against Rheumatism 1, 6
Pre-Referral Workup
- Before referring to rheumatology, obtain ESR and CRP, HLA-B27 testing, complete blood count, and consider plain radiographs of sacroiliac joints (though MRI is more sensitive), as recommended by the American College of Rheumatology 8